Trial Profile
Effect of Renin Inhibition on Cardiovascular Autonomic Nerve Function in Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Diabetic cardiomyopathy
- Focus Pharmacodynamics
- 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Aug 2009 New trial record